Invention Grant
- Patent Title: Antibodies that bind IL-4 and/or IL-13 and their uses
- Patent Title (中): 结合IL-4和/或IL-13的抗体及其用途
-
Application No.: US12682864Application Date: 2008-10-14
-
Publication No.: US08388965B2Publication Date: 2013-03-05
- Inventor: Ercole Rao , Vincent Mikol , Danxi Li , Jochen Kruip , Matthew Davison
- Applicant: Ercole Rao , Vincent Mikol , Danxi Li , Jochen Kruip , Matthew Davison
- Applicant Address: FR Paris
- Assignee: Sanofi
- Current Assignee: Sanofi
- Current Assignee Address: FR Paris
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Agent J. Darrell Fontenot; Ann Marie Szczepanik
- Priority: EP07291259 20071015
- International Application: PCT/US2008/079787 WO 20081014
- International Announcement: WO2009/052081 WO 20090423
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24
Abstract:
The present invention relates to novel humanized anti-IL-4 and IL-13 antibodies and fragments thereof and novel bispecific antibodies and fragments thereof that specifically bind to IL-4 and IL-13. The invention also includes uses of the antibodies to treat or prevent IL-4 and/or IL-13 mediated diseases or disorders, including allergic asthma and dermatitis.
Public/Granted literature
- US20100226923A1 ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES Public/Granted day:2010-09-09
Information query
